Healthcare >> Analyst Interviews >> June 2, 2004
DAVID MOSKOWITZ is Managing Director of the healthcare research group at
Friedman, Billings, Ramsey Group, Inc. He joined FBR in July 2001 and
currently covers the large cap pharmaceutical sector in addition to
select specialty pharmaceutical companies. From 1999 to 2001, Mr.
Moskowitz worked for UBS Warburg as a specialty pharmaceuticals analyst,
and from 1998 to 1999, he was a biotechnology analyst for Standard &
Poor's. Prior to entering the financial services industry, Mr. Moskowitz
practiced as a Registered Pharmacist in various hospital and retail
settings for nearly 10 years. Mr. Moskowitz received his BS degree in
Pharmacy from Rutgers University and his MBA degree in Finance and
Pharmaceutical Industry Studies from Fairleigh Dickinson University. Profile
Billings, Ramsey.
Mr. Moskowitz: I cover two sectors in the drug segment, the large cap
pharmaceutical stocks and some
